Clinical Trial Update: Intravenous rhMBL in Patients With Multiple Myeloma Receiving Chemotherapy Followed by Stem Cell Transplant [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating intravenous rhMBL in patients with multiple myeloma receiving chemotherapy and stem cell transplant has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• rhMBL (recombinant human mannose-binding lectin)

Snippet

Sponsor: Enzon Pharmaceuticals, Inc. | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED